Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the <scp>CANVAS</scp> Program and <scp>CREDENCE</scp> trial
Diabetes, obesity & metabolism/Diabetes, obesity and metabolism